Pages that link to "Q42491575"
Jump to navigation
Jump to search
The following pages link to Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer (Q42491575):
Displaying 50 items.
- Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer (Q26739706) (← links)
- A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth (Q28116222) (← links)
- PBOV1 is a human de novo gene with tumor-specific expression that is associated with a positive clinical outcome of cancer (Q28708968) (← links)
- Molecular signature of cancer at gene level or pathway level? Case studies of colorectal cancer and prostate cancer microarray data (Q30588294) (← links)
- Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data (Q33490254) (← links)
- Establishment and genomic characterization of mouse xenografts of human primary prostate tumors (Q33745240) (← links)
- Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo (Q33778211) (← links)
- Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression (Q33866927) (← links)
- Yes-Associated Protein Expression Is Correlated to the Differentiation of Prostate Adenocarcinoma (Q33925616) (← links)
- Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression (Q33948926) (← links)
- Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue (Q34000269) (← links)
- Systems analysis of the prostate tumor suppressor NKX3.1 supports roles in DNA repair and luminal cell differentiation (Q34078166) (← links)
- HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation. (Q34616703) (← links)
- Estrogen-dependent dynamic profile of eNOS-DNA associations in prostate cancer (Q34712579) (← links)
- A novel dysregulated pathway-identification analysis based on global influence of within-pathway effects and crosstalk between pathways. (Q34775286) (← links)
- Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex (Q35595690) (← links)
- MetaQC: objective quality control and inclusion/exclusion criteria for genomic meta-analysis (Q35672164) (← links)
- ksRepo: a generalized platform for computational drug repositioning (Q35918546) (← links)
- Regulators of gene expression as biomarkers for prostate cancer (Q36439912) (← links)
- β4 Integrin signaling induces expansion of prostate tumor progenitors (Q36580342) (← links)
- Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties (Q36609221) (← links)
- Identification of common tumor signatures based on gene set enrichment analysis. (Q36630265) (← links)
- Candidate cancer-targeting agents identified by expression-profiling arrays (Q36802115) (← links)
- 12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression (Q36913759) (← links)
- Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development (Q36959438) (← links)
- Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia (Q37095364) (← links)
- Current management of prostate cancer: dilemmas and trials (Q37102535) (← links)
- Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. (Q37150826) (← links)
- Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer (Q37170747) (← links)
- FOG2 protein down-regulation by transforming growth factor-β1-induced microRNA-200b/c leads to Akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy. (Q37311890) (← links)
- The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling (Q37331195) (← links)
- The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells (Q37426771) (← links)
- DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11. (Q37445288) (← links)
- The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy (Q37709925) (← links)
- Diagnostic and prognostic molecular biomarkers for prostate cancer (Q37972703) (← links)
- Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells. (Q38421322) (← links)
- The role of nuclear endothelial nitric oxide synthase in the endothelial and prostate microenvironments. (Q38471524) (← links)
- C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition. (Q38964120) (← links)
- MALAT1 and HOTAIR Long Non-Coding RNAs Play Opposite Role in Estrogen-Mediated Transcriptional Regulation in Prostate Cancer Cells. (Q39127487) (← links)
- Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo (Q39732250) (← links)
- Dynein axonemal heavy chain 8 promotes androgen receptor activity and associates with prostate cancer progression (Q41263669) (← links)
- GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics (Q41981512) (← links)
- Network information improves cancer outcome prediction (Q42681658) (← links)
- Anacardic acid and thyroid hormone enhance cardiomyocytes production from undifferentiated mouse ES cells along functionally distinct pathways (Q47622945) (← links)
- Cell‐cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells (Q53302883) (← links)
- Nucleoporin 153 regulates estrogen-dependent nuclear translocation of endothelial nitric oxide synthase and estrogen receptor beta in prostate cancer. (Q55513463) (← links)
- Genetic profile identification in clinically localized prostate carcinoma (Q62581225) (← links)
- Linking the septin expression with carcinogenesis (Q83096922) (← links)
- EAF2 loss induces prostatic intraepithelial neoplasia from luminal epithelial cells in mice (Q90643584) (← links)
- Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence (Q91152079) (← links)